Product: CD168 Antibody
Catalog: DF4809
Description: Rabbit polyclonal antibody to CD168
Application: WB IHC IF/ICC
Reactivity: Human
Prediction: Pig, Horse, Dog
Mol.Wt.: 85 KD; 84kD(Calculated).
Uniprot: O75330
RRID: AB_2837160

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human
Prediction:
Pig(80%), Horse(80%), Dog(80%)
Clonality:
Polyclonal
Specificity:
CD168 Antibody detects endogenous levels of total CD168.
RRID:
AB_2837160
Cite Format: Affinity Biosciences Cat# DF4809, RRID:AB_2837160.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

CD168; CD168 antigen; HMMR; HMMR_HUMAN; Hyaluronan mediated motility receptor; Hyaluronan-mediated motility receptor (RHAMM); IHABP; Intracellular hyaluronic acid-binding protein; MGC119494; MGC119495; OTTHUMP00000196920; Receptor for hyaluronan-mediated motility; RHAMM;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
O75330 HMMR_HUMAN:

Expressed in breast cancer cell lines and in normal breast tissue.

Sequence:
MSFPKAPLKRFNDPSGCAPSPGAYDVKTLEVLKGPVSFQKSQRFKQQKESKQNLNVDKDTTLPASARKVKSSESKESQKNDKDLKILEKEIRVLLQERGAQDRRIQDLETELEKMEARLNAALREKTSLSANNATLEKQLIELTRTNELLKSKFSENGNQKNLRILSLELMKLRNKRETKMRGMMAKQEGMEMKLQVTQRSLEESQGKIAQLEGKLVSIEKEKIDEKSETEKLLEYIEEISCASDQVEKYKLDIAQLEENLKEKNDEILSLKQSLEENIVILSKQVEDLNVKCQLLEKEKEDHVNRNREHNENLNAEMQNLKQKFILEQQEREKLQQKELQIDSLLQQEKELSSSLHQKLCSFQEEMVKEKNLFEEELKQTLDELDKLQQKEEQAERLVKQLEEEAKSRAEELKLLEEKLKGKEAELEKSSAAHTQATLLLQEKYDSMVQSLEDVTAQFESYKALTASEIEDLKLENSSLQEKAAKAGKNAEDVQHQILATESSNQEYVRMLLDLQTKSALKETEIKEITVSFLQKITDLQNQLKQQEEDFRKQLEDEEGRKAEKENTTAELTEEINKWRLLYEELYNKTKPFQLQLDAFEVEKQALLNEHGAAQEQLNKIRDSYAKLLGHQNLKQKIKHVVKLKDENSQLKSEVSKLRCQLAKKKQSETKLQEELNKVLGIKHFDPSKAFHHESKENFALKTPLKEGNTNCYRAPMECQESWK

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
80
Horse
80
Dog
80
Bovine
78
Sheep
67
Xenopus
60
Rabbit
60
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - O75330 As Substrate

Site PTM Type Enzyme
S2 Phosphorylation
S20 Phosphorylation
S41 Phosphorylation
S65 Phosphorylation
T110 Phosphorylation
K114 Ubiquitination
K138 Ubiquitination
T198 Phosphorylation
S205 Phosphorylation
K215 Ubiquitination
K221 Ubiquitination
Y250 Phosphorylation
K251 Ubiquitination
K338 Ubiquitination
K350 Ubiquitination
S353 Phosphorylation
K419 Ubiquitination
K489 Ubiquitination
K604 Ubiquitination
K635 Ubiquitination
S656 Phosphorylation
K696 Ubiquitination
T703 Phosphorylation
Y713 Phosphorylation

Research Backgrounds

Function:

Receptor for hyaluronic acid (HA) (By similarity). Involved in cell motility (By similarity). When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular-regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity).

Subcellular Location:

Cell surface. Cytoplasm.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Expressed in breast cancer cell lines and in normal breast tissue.

Subunit Structure:

Subunit of the HARC complex. Interacts with ANKRD26.

Research Fields

· Environmental Information Processing > Signaling molecules and interaction > ECM-receptor interaction.   (View pathway)

References

1). Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma. Frontiers in immunology, 2024 (PubMed: 38633247) [IF=7.3]

Application: WB    Species: Human    Sample: HCC cells

Figure 3 Knockdown of HMMR inhibited proliferation and invasion of HCC cells. (A) The knockdown efficiency of si-HMMRs have been testified by western blot in SMMC-7721, Huh7 and LM3. (B, C) The results of clone assays. (D, E) The results of Edu assays. (F, G) The results of wound healing assays.**P

2). The critical role of B4GALT4 in promoting microtubule spindle assembly in HCC through the regulation of PLK1 and RHAMM expression. JOURNAL OF CELLULAR PHYSIOLOGY, 2022 (PubMed: 34270095) [IF=5.6]

Application: WB    Species: Human    Sample: HepG2 cells

FIGURE 9 B4GALT4 knockdown regulated TGF‐beta1/TGF‐beta receptor‐1 signaling pathway and modified the expressions of PLK1 and RHAMM. (a) B4GALT4 knockdown downregulated the expression of lumican. (b) The expressions of B4GALT4, P‐Smad2, Smad2, PLK1, and RHAMM in HepG2 cells after different treatments as mentioned above were detected by Western blot analysis. (c) The comparison of the mRNA expression level of HMMR between tumor and normal samples. (d) Survival analysis of HMMR in HCC. (e) The protein interaction network diagram of RHAMM, PLK1, and other pathway‐related genes. (f) ChIP‐seq results showed that Smad2/3 and p300 binding regions are enriched around the promoter of PLK1. (g) Schematic illustration of the B4GALT4‐mediated regulatory network responsible for the microtubule spindle assembly in HCC (****p<0.0001). B4GALT, beta 1,4‐galactosyltransferase; HCC, hepatocellular carcinoma; mRNA, messenger RNA

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.